Molecular Farming Case Study: Phillip Morris International

Phillip Morris International (PMI), the global tobacco giant that sells cigarettes in over 200 countries, manufactures and markets Marlboro. Marlboro the number one cigarette brand, which holds more than 9% market share by volume worldwide (excluding China and USA cigarette volumes). . The first Marlboro cigarettes manufactured outside the U.S. are produced following an agreement with Fabriques de Tabac Réunies in Switzerland in 1957. This manufacturing facility is subsequently acquired by Philip Morris in 1963. Phillip Morris International opens their industries in Asia in 1995 located in Seremban where it’s the first factory in Asia. After that, PMI build up their factory in Philippines where PMI company largest investment in Asia.
In addition,

So, with this changes not only modified tobacco plants because it puts DNA in the leaves of mature plants that a produce a protein for protect against the flu. This is one of the benefits of molecular farming that gives advantages towards human life especially for protect human health among people in China.
Secondly, vaccine will produce faster and cheaper than traditional methods. This is because, Medicago specializes in producing flu vaccines from Nicotiana benthamiana, a relative of Nicotiana tabacum, the tobacco plant used in cigarettes. It represents one of several plant and cell-based alternatives to chicken eggs, which have been used for decades to make vaccines but are seen as slow and expensive.
Besides that, molecular farming on animal should have higher cost for safety, storage and transport rather than molecular farming on plants. So, with the molecular farming in plants can produce more flu vaccine for China and sell that flu vaccine with the cheaper price because lower cost, storage and